November 11, 2025 a 01:00 pm
CAH: Analysts Ratings - Cardinal Health, Inc.
Cardinal Health, Inc., a leading player in healthcare services and products, remains the focus of various analyst recommendations. The company's dual segment operation allows it to tap into pharmaceutical and medical supply markets, potentially stabilizing its revenue streams. This diverse portfolio grants Cardinal Health resilience against sectoral downturns. However, shifts in analyst ratings may indicate evolving market sentiments towards its growth and risk prospects.
Historical Stock Grades
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 10 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment Development
Over the last few months, the sentiment towards Cardinal Health's stock has shown relatively stable metrics with minor shifts. While 'Buy' ratings dominate, there has been a consistent presence of 'Hold' ratings, implying a balanced view between bullish and cautious outlooks.
- The total number of ratings has maintained around similar figures, suggesting analysts closely follow market movements.
- A slight increase noticed in 'Hold' ratings over previous months, likely pointing to increasing caution.
- 'Strong Buy' ratings have remained limited, possibly affected by broader industry trends.
Percentage Trends
A more detailed look at rating percentages offers insight into market sentiment deliberations. Over recent months, the balance between 'Buy' and 'Hold' recommendations has been notable. Although the 'Strong Buy' percentage is minimal, the significant 'Buy' count supports a bullish stance from analysts.
- 'Buy' ratings constitute around 62% in recent evaluations, while 'Hold' remains steady at approximately 25%.
- The shift indicates a move towards a more cautious yet positive outlook, with 'Buy' prevailing over more conservative ratings.
- Key changes over the last year show decreased 'Strong Buy' and increased 'Hold,' reflecting careful optimism aligned with broader sector dynamics.
Latest Analyst Recommendations
The most recent analyst activities showcase a consensus of maintaining previous ratings with strong continuity. This stability could indicate confidence in the company's current market position and future prospects.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-05 | Overweight | Overweight | Wells Fargo |
| 2025-11-04 | Outperform | Outperform | Mizuho |
| 2025-11-03 | Buy | Buy | TD Cowen |
| 2025-10-31 | Neutral | Neutral | Citigroup |
| 2025-10-31 | Buy | Buy | UBS |
Analyst Recommendations with Change of Opinion
There were notable adjustments in analyst perspectives in previous months, seen in upgrades in recommendations. These changes could signal strategic improvements within the company or a positive outlook for industry conditions.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-03 | Overweight | Equal Weight | Wells Fargo |
| 2025-02-05 | Buy | Hold | Jefferies |
| 2025-01-08 | Buy | Hold | TD Cowen |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2025-01-06 | Buy | Neutral | B of A Securities |
Interpretation
Considering the overall analyst sentiment, Cardinal Health's stock appears to be positioned firmly with a predominantly positive outlook. While 'Buy' recommendations demonstrate confidence in its operational stability, the persistent 'Hold' ratings point to some market caution. The recent steady recommendations suggest limited new concerns but also no significant positive catalysts. Overall, the current analyst view does not highlight immediate volatility, favoring a cautiously optimistic stance.
Conclusion
Cardinal Health, Inc.'s robust positioning in a critical sector coupled with a strong base of 'Buy' recommendations supports a favorable outlook, albeit tempered with caution due to consistent 'Hold' ratings. Shifts in sentiment towards a more restrained recognition reveal an underlying assurance balanced with awareness of industry volatility. The recent preservation of ratings alongside strategic upgrades suggests a maintained confidence bolstered by ongoing operational strengths, while vigilance against sector fluctuations remains crucial. As analysts continue to closely monitor the healthcare landscape, Cardinal Health stands out as a firm with viable growth potential tempered by prudent observance.